Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China · Delayed Price · Currency is CNY 127.15
+1.15 (0.91%)
At close: May 28, 2026
SHE:301093 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 42.41 | 60.18 | 49.57 | 117.93 | 93.75 | 216.02 |
Depreciation & Amortization | 67.15 | 67.15 | 56.45 | 44.45 | 34.84 | 28.11 |
Other Amortization | 13.91 | 13.91 | 18.12 | 17.77 | 18.58 | 12.64 |
Loss (Gain) From Sale of Assets | 0.54 | 0.54 | -0 | -0.21 | -0.24 | -0 |
Asset Writedown & Restructuring Costs | 0.03 | 0.03 | 0.05 | 0.04 | 0.81 | 0.02 |
Loss (Gain) From Sale of Investments | -15.26 | -15.26 | -21.93 | -48.62 | -34.96 | - |
Provision & Write-off of Bad Debts | 1.47 | 1.47 | 0.45 | -1.04 | 1.58 | 2.39 |
Other Operating Activities | 37.82 | 2.15 | 2.91 | 0.01 | 2.22 | 6.54 |
Change in Accounts Receivable | -1.68 | -1.68 | 14.69 | -10.74 | -17.91 | -72.4 |
Change in Inventory | -28 | -28 | -36.28 | 23.61 | 12.23 | -47 |
Change in Accounts Payable | 2.64 | 2.64 | 4.3 | 30.1 | -29.5 | 67.13 |
Change in Other Net Operating Assets | 13.48 | 13.48 | 34.8 | 57.75 | 10.24 | 2.44 |
Operating Cash Flow | 133.39 | 115.49 | 120.78 | 223.85 | 94.88 | 216.54 |
Operating Cash Flow Growth | 313.11% | -4.38% | -46.05% | 135.93% | -56.18% | 62.32% |
Capital Expenditures | -141.52 | -132.59 | -135.43 | -297.25 | -173.62 | -123.76 |
Sale of Property, Plant & Equipment | 0.35 | 0.72 | 0.03 | 0.42 | 1.14 | 0.4 |
Investment in Securities | -145.46 | -32 | 234.28 | 365.04 | -1,524 | - |
Other Investing Activities | 17.09 | 25.11 | 46.57 | 36.71 | 11.09 | -1.19 |
Investing Cash Flow | -269.41 | -138.76 | 145.46 | 104.92 | -1,685 | -124.55 |
Short-Term Debt Issued | - | - | - | 20 | - | 131.8 |
Long-Term Debt Issued | - | 126 | - | - | - | - |
Total Debt Issued | 126 | 126 | - | 20 | - | 131.8 |
Short-Term Debt Repaid | - | - | - | -20 | - | -211.93 |
Long-Term Debt Repaid | - | -41.1 | -0.48 | - | -40.38 | - |
Total Debt Repaid | -44.1 | -41.1 | -0.48 | -20 | -40.38 | -211.93 |
Net Debt Issued (Repaid) | 81.9 | 84.9 | -0.48 | - | -40.38 | -80.13 |
Issuance of Common Stock | - | - | 11.15 | 12.28 | - | 1,955 |
Repurchase of Common Stock | -107.73 | -107.73 | -230.65 | -27 | - | - |
Common Dividends Paid | -26.19 | -26.19 | -77.65 | -40.93 | -94.9 | -4.47 |
Other Financing Activities | 40.5 | 32.74 | - | - | - | -147.55 |
Financing Cash Flow | -11.51 | -16.27 | -297.63 | -55.66 | -135.28 | 1,723 |
Foreign Exchange Rate Adjustments | -0.91 | 0.13 | 0.13 | 1.26 | -0.35 | -1.7 |
Net Cash Flow | -148.43 | -39.41 | -31.27 | 274.37 | -1,726 | 1,814 |
Free Cash Flow | -8.12 | -17.09 | -14.65 | -73.39 | -78.73 | 92.78 |
Free Cash Flow Growth | - | - | - | - | - | -1.15% |
Free Cash Flow Margin | -1.35% | -2.76% | -2.50% | -11.78% | -13.48% | 11.30% |
Free Cash Flow Per Share | -0.05 | -0.10 | -0.09 | -0.41 | -0.45 | 0.67 |
Cash Income Tax Paid | 24.05 | 22.72 | 39.5 | 40.62 | 34.69 | 80.41 |
Levered Free Cash Flow | -58.1 | -34.18 | -37.44 | -125.09 | -100.43 | 33.66 |
Unlevered Free Cash Flow | -57.01 | -33.33 | -37.29 | -124.81 | -100.05 | 36.68 |
Change in Working Capital | -14.68 | -14.68 | 15.15 | 93.53 | -21.69 | -49.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.